NCT00492050 2026-03-11Bortezomib and Rituximab for Patients With Waldenstrom's MacroglobulinemiaM.D. Anderson Cancer CenterPhase 2 Active not recruiting46 enrolled 10 charts
NCT02339922 2026-03-05Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin LymphomaUniversity of WashingtonPhase 2 Active not recruiting33 enrolled 16 charts
NCT02180724 2025-11-26An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström MacroglobulinemiaAcerta Pharma BVPhase 2 Active not recruiting107 enrolled 15 charts
NCT04273139 2025-07-30Ibrutinib + Venetoclax in Untreated WMDana-Farber Cancer InstitutePhase 2 Active not recruiting45 enrolled 15 charts
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts